Distribution agreement via Elemental Healthcare

RNS Number : 1518G
Surgical Innovations Group PLC
28 February 2018

Surgical Innovations Group plc

("Surgical Innovations")


Elemental Healthcare extend Microline inc. distribution agreement


Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of innovative technology for minimally invasive surgery ("MIS"), announces that its wholly owned subsidiary, Elemental Healthcare Limited, has signed an additional three year exclusive UK distribution agreement with Microline Surgical Inc, Boston USA ("Microline") which was due for renewal on 31 March 2018.  Microline manufactures instruments for MIS that are complementary to the Surgical Innovations branded range.  The new distribution agreement is expected to generate revenue of an estimated £7m over the duration of the contract.


David Marsh, Group Commercial Director of Surgical Innovations Group plc, commented: "Microline has been one of the cornerstones of the Elemental Healthcare business for the last ten years and we are delighted to continue this partnership. Microline share the same ethos of cost containment and reduction in clinical waste as Surgical Innovations, allowing Elemental Healthcare to provide unique solutions to the NHS and private healthcare providers which make significant savings with procedural kits."


Johan van Doremalen, General Manager EMEA, Microline Surgical BV commented: "Elemental Healthcare has been an important partner for us in Europe for nearly 10 years and we are delighted to continue this relationship with one of the leading MIS distributors in the UK."




For further information please contact:


Surgical Innovations Group plc


Nigel Rogers, Executive Chairman

Tel: 0113 230 7597

Melanie Ross, COO & CFO




WH Ireland Limited (NOMAD & Broker)

Tel: 0113 394 6600

Tim Feather

Alex Bond




Walbrook PR  (Financial PR & Investor Relations)

Tel: 020 7933 8780 or si@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

                                                 Mob: 07584 391 303


This information is provided by RNS
The company news service from the London Stock Exchange
UK 100